Nucleosidi

3’-b-C-Methyl-5-methyluridine is a phosphoramidite that is used as an antiviral agent. It is also known as (2’,3’)-O-(2-methoxyethyl) 5'-O-(4,4'-dimethoxytrityl)thymidine or 3’-b-C-Methyluridine. It has been shown to have anticancer properties in vitro and in vivo, and it can be used for the treatment of prostate cancer. 3’-b-C-Methyluridine is synthesized by the reaction of uracil with bis(trimethylsilyl)acetamide followed by reaction with methylamine. The synthesis of this drug was first reported in 1975.

<p>2-Amino-1-(b-D-arabinofuranosyl)-5-methyl-4(1H)-pyrimidinone (araA) is an activator of nucleoside synthesis. It is a novel and versatile chemical that can be used to produce both ribonucleosides and deoxyribonucleosides. AraA is a potent antiviral and anticancer agent that has been shown to inhibit the growth of cancer cells in vitro. AraA is a modified form of 2′,3′-dideoxyadenosine, which is synthesized by enzymatic modification of natural 2′,3′ dideoxythymidine.</p>

<p>N6-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-trityladenosine 3'-CE phosphoramidite is a novel modified nucleoside. It is an antiviral and anticancer agent that has been shown to inhibit the replication of DNA in vitro. It also inhibits the synthesis of RNA and protein, which may contribute to its anti-cancer properties. N6-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-trityladenosine 3'-CE phosphoramidite is synthesized from 2,6,8 trichloroquinoline and 2,3,4 trimethoxybenzaldehyde via a novel process with high purity.</p>

Cytidine is a pyrimidine nucleoside that is important in the synthesis of RNA and DNA. Cytidine deaminase is an enzyme that catalyzes the conversion of cytidine to uridine. Cytidine deaminase has been shown to be inhibited by its substrate, cytidine, and by other compounds that are structurally similar to cytidine such as uracil, thymine, and guanine. Cytidine deaminase has been shown to have a role in the development of autoimmune diseases and HIV infection. This enzyme also has an important role in the polymerization of DNA during replication. Cytidine can be used for transfection experiments and to inhibit viral replication.

<p>3-Methyl-2-nitropyridine is a high yield byproduct of formamide, which can be activated to form an intermediate for the synthesis of nucleosides. The kinetics and labeling of this intermediate were studied using a transfer experiment. 3-Methyl-2-nitropyridine is acidic, with a pKa value of 3.6, and is reactive towards nucleophiles. It is also catalytic, yielding methyl groups and dioxane as products when heated at temperatures between 180°C and 220°C. In addition, it undergoes nucleophilic substitutions at methoxy groups.</p>

<p>An intermediate for the preparation of modified oligonucleotides and other uridine derivatives containing a 2',2'-difluoro modification.</p>

N4-Benzoyl-2'-deoxycytidine is a fluorescent nucleoside that has been used to study the molecular interactions between sugar residues and the phosphate groups of nucleic acids. It is used as a reagent for glycosidation, which involves the formation of a glycosidic linkage between an alcohol group in a saccharide or oligosaccharide and the hydroxyl group in an aromatic acid. N4-Benzoyl-2'-deoxycytidine has also been synthesized by solid-phase techniques. This synthetic method is based on phosphoramidite chemistry and uses an automated DNA synthesizer to produce oligonucleotides with specific sequences. The synthesis of this nucleoside relies on the use of fluorescent dyes such as fluorescein, rhodamine, and coumarin to monitor progress during synthesis.

<p>4'-Thiothymidine is a nucleoside analog that is used in antiviral therapy against herpes simplex virus. It inhibits the viral DNA polymerase, which prevents the virus from duplicating its genetic material. 4'-Thiothymidine has been shown to inhibit the uptake of 4-thiouracil by cells and to have anti-inflammatory properties. The drug has been found to be effective in inhibiting human adenocarcinoma cell lines in vitro and in vivo.</p>

<p>N6-Benzoyl-5'-O-benzoyl-2'-deoxyadenosine is an antiviral and anticancer compound. It has been shown to be active against a number of viruses, including human immunodeficiency virus type 1 (HIV-1), herpes simplex virus type 1, and influenza A virus. It also inhibits DNA polymerase α and β by competitive inhibition, preventing the incorporation of ribonucleotides into DNA. This compound may be used for the treatment of AIDS or as a cytostatic agent for the treatment of leukemia or lymphoma.</p>

<p>5'-Deoxy-5'-(methylthio)adenosine is a nucleoside that has been shown to inhibit the growth of bowel cancer cells. 5'-Deoxy-5'-(methylthio)adenosine blocks the synthesis of DNA and RNA by inhibiting the action of enzymes involved in DNA metabolism. It also inhibits methionine synthase and phosphorylase, which are involved in protein synthesis. This compound has been shown to be effective in treating cancer tissues due to its ability to inhibit polymerase chain reactions and prevent the formation of cancerous cells.</p>

<p>3'-Azido-2',3'-dideoxy-5'-O-p-toluoyluridine is a novel, activator ribonucleotide that has been shown to inhibit the proliferation of cancer cells and human immunodeficiency virus (HIV) with high potency. This compound is a nucleoside analog that is synthesized from diphosphate, phosphoramidites, and modified nucleosides. 3'-Azido-2',3'-dideoxy-5'-O-p-toluoyluridine has been shown to inhibit the growth of tumor cells in vitro and in vivo by arresting cell cycle progression at G1 phase. The mechanism of action for this drug is not fully understood; however, it may be related to its ability to induce apoptosis.</p>

<p>The phosphoramidite 7-Deaza-2'-deoxy-7-iodoguanosine is a modified nucleotide that is used in the synthesis of DNA. This compound has antiviral and anticancer properties, as it inhibits viral replication by preventing the synthesis of viral RNA or DNA. It also prevents the production of cancer cells by inhibiting ribonucleotide reductase, an enzyme that reduces ribonucleotides to deoxyribonucleotides for DNA synthesis. The purity of this product is high and the novel nature of this product makes it a valuable reagent for research.</p>

5'-O-DMT-2'-O-methyl-5-methyluridine is a modified nucleoside that is used in the synthesis of DNA. It is an anticancer drug and antiviral agent. 5'-O-DMT-2'-O-methyl-5-methyluridine has been shown to inhibit the growth of leukemia cells, even when they are resistant to other drugs. It also inhibits certain viruses, such as herpes simplex virus type 1 (HSV1), by preventing viral replication and inhibiting protein synthesis. This nucleoside is synthesized from 5'-O-DMT and 2'-O-methylcytosine.

<p>7-Deaza-2'-deoxy-6-methoxyguanosine is a modified nucleoside and antiviral agent. It has been shown to inhibit the synthesis of DNA, RNA and protein in cells infected with the herpes simplex virus (HSV). 7-Deaza-2'-deoxy-6-methoxyguanosine is also an anticancer agent that has been shown to inhibit tumor growth in animal models. This compound is synthesized by phosphoramidite chemistry and is a novel precursor for the preparation of modified DNA and RNA. The purity of this product is greater than 98%.</p>

2-Methylmercapto-4-oxo-6-aminopyrimidine monohydrate is a chemical substance that is used as an anticancer and antiviral agent. It has been demonstrated to inhibit the proliferation of tumor cells in vitro and in vivo, and to deplete tumor cell lines of the enzyme ribonucleotide reductase, which is essential for DNA synthesis. The compound also inhibits the synthesis of viral nucleic acid. 2MMAP has a novel chemical structure that includes a methyl group attached to one nitrogen atom. This modification increases its affinity for DNA and RNA molecules by binding to the phosphate groups on these molecules.

5'-O-tert-Butyldiphenylsilyl-7-deaza-2'-deoxy-7-iodoadenosine is a novel synthetic nucleoside with antiviral and antitumor activities. It has been shown to inhibit the activity of the HIV virus by preventing DNA replication. 5'-O-tert-Butyldiphenylsilyl-7-deaza-2'-deoxy-7-iodoadenosine also inhibits the synthesis of RNA and proteins, which can lead to cell death. The compound's high purity and quality are ensured by its CAS number.

<p>5’-Deoxy-N4-dimethyl-5-fluorocytidine is a novel antiviral agent that inhibits the synthesis of viral RNA. It is synthesized by the de novo purine nucleotide biosynthesis pathway and is activated by phosphorylation to a 5'-diphosphate. This compound has been shown to inhibit the replication of herpes simplex virus type 1 in cell culture. In addition, it has been shown to have anticancer activity against human leukemia cells in vitro and in vivo.</p>

5-Hydroxymethyl-2’C-methyluridine is a modified nucleoside that is an activator of cellular DNA synthesis. It is a synthetic compound that has been shown to be active against cancer cells in vitro. 5-Hydroxymethyl-2’C-methyluridine has also been used to inhibit the replication of various viruses, including herpes simplex virus type 1 and 2, cytomegalovirus, and human immunodeficiency virus type 1. This drug was shown to be safe and effective in clinical trials for the treatment of HIV/AIDS patients with no adverse side effects.

<p>Morpholino C monomer is a nucleoside amidite used to prepare morpholino oligomers</p>

<p>7-Deaza-4-Cl-2'-deoxyguanosine is a novel antiviral drug that has been synthesized in the laboratory. It is an analogue of deoxyguanosine, a nucleoside that is found in DNA and RNA. 7-Deaza-4-Cl-2'-deoxyguanosine has anti cancer properties because it inhibits the synthesis of DNA by inhibiting the activity of ribonucleoside reductase, an enzyme that converts ribonucleosides to deoxyribonucleosides. This drug has been shown to have potent anticancer activity against human lung cancer cells and mouse leukemia cells.</p>

Cyclopentenyl cytosine 5'-triphosphate sodium salt is a synthetic, activator diphosphate. It is used as a phosphoramidite in the synthesis of DNA and RNA. Cyclopentenyl cytosine 5'-triphosphate sodium salt has been shown to have anticancer and antiviral properties.

<p>N4-Acetyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine 3'-CE phosphoramidite is a novel nucleoside analogue with antiviral and anticancer potential. It is a modified nucleoside that contains an acetyl group at the 4' position. The 3'-OH group has been replaced by a tertiary butyldimethylsilyl group, which renders the compound resistant to deamination by nucleases. N4-Acetyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine 3'-CE phosphoramidite also shows high purity and high quality.</p>

<p>1-(3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-b-D-arabinofuranosyl)thymine is a chemically modified nucleoside analog. This compound contains a thymine base, a 2'-fluoro-β-D-arabinofuranose sugar, which alters biological stability and function and benzoyl protecting groups at the 3' and 5' positions, commonly used in nucleoside synthesis to control selective modifications.</p>

Used for energy storage and in nucleic acid metabolism

2'/3'-(N-Methylanthraniloyl)-adenosine-5'-monophosphate triethylammonium salt is an antiviral agent that is based on ribonucleosides. This drug has been shown to be effective against cancer and herpes simplex virus type 1 (HSV-1) and may have potential as a treatment for HIV. It also inhibits the growth of tumors in animal models. 2'/3'-(N-Methylanthraniloyl)-adenosine-5'-monophosphate triethylammonium salt is synthesized by reacting ribonucleosides with N-(2,2,2,-trimethylpropyl)anthranilic acid chloride in the presence of triethylamine. The resulting product can be purified by column chromatography or recrystallization.

1-(2-C-Methyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one is an antiviral agent that belongs to the class of monophosphate deoxyribonucleosides. It is a novel compound that has been shown to be an activator of high purity and quality. 1-(2-C-Methyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one is synthesized from modified ribonucleosides and phosphoramidites. The antiviral activity of this drug against DNA viruses (e.g., herpes, adenovirus) and RNA viruses (e.g., influenza virus) has been shown in vitro and in vivo. In addition, 1-(2-C-Methyl-b--D--ribofuranosyl)-5--nitropyridine--2(1H)--

<p>Adenosine 5'-O-(3-thiotriphosphate), BODIPY FL thioester sodium salt - 5mM buffered aqueous solution is a novel nucleoside that is synthesized from the corresponding phosphoramidites. This compound is an activator of DNA synthesis in mammalian cells and a potent inhibitor of viral replication. It has antiviral activity against HIV, herpes, and influenza viruses. The molecule can be modified to include different substituents such as fluoro, bromo, or chloro groups and has been shown to have anticancer activity.</p>

Acetoacetyl coenzyme A lithium salt is a novel phosphoramidite building block. It's a modified nucleoside that can be used in the synthesis of oligonucleotides and DNA. Acetoacetyl coenzyme A lithium salt has antiviral, anticancer, and antifungal activities.

<p>Akt activation inhibitor</p>

<p>2',3',5'-Tri-O-acetyladenosine is a chemically protected form of adenosine with potential for use as an intermediate in nucleoside synthesis and nucleic acid chemistry. The hydroxyl (–OH) groups at the 2′, 3′, and 5′ positions of the ribose are protected by acetyl groups (–COCH₃), which can prevent unwanted chemical reactions during chemical synthesis.</p>

5-Hydroxymethylcytidine is a nucleoside that has been shown to inhibit the activity of RNA polymerase by forming hydrogen bonds with the enzyme. It is used in vitro to study the role of messenger RNA in regulating gene expression, and also as a probe for transcriptase activity. 5-Hydroxymethylcytidine has also been shown to have a biological function in solid tumours and may be an analytical method for detecting cancer.

<p>N2-Isobutyryl-2'-deoxy-5'-O-pixylguanosine is a modified nucleotide that has been shown to be an activator of the protein kinase C and may have anticancer and antiviral properties. N2-Isobutyryl-2'-deoxy-5'-O-pixylguanosine is a synthetic nucleoside that is structurally similar to ribonucleosides and deoxyribonucleosides, but contains a modified base. The nucleotide is activated by phosphorylation and then undergoes hydrolysis in the cell to form diphosphate. This product has CAS No. 125965-04-3, purity at 99%, and high quality.</p>

<p>5'-O-tert-Butyldimethylsilyl-2,2'-anhydrouridine is a modified nucleoside that has been used as an anticancer agent and antiviral and antifungal agent. It has been shown to inhibit the growth of tumor cells in animal models by inhibiting DNA synthesis and repair. 5'-O-tert-Butyldimethylsilyl-2,2'-anhydrouridine is also able to bind to RNA with high affinity, making it a potential candidate for use as an antiviral agent against HIV. This compound does not occur naturally in cells and can be synthesized from other nucleosides.</p>

3'-Amino-5'-O-p-anisoyl-3'-deoxythymidine is an antiviral agent that is a monophosphate prodrug of 3'-deoxy-5'-O-(4,4'-diaminodiphenylsulfone)thymidine. It is a novel compound with high quality, high purity, and good solubility in water. It has been shown to be an activator of cellular DNA polymerase and ribonucleosides reductase, as well as having anticancer activity. 3'-Amino-5'-O-p-anisoyl-3'-deoxythymidine has been shown to inhibit the growth of human tumor cells in vitro.

<p>Inosine-5'-diphosphate disodium salt (IDPS) is a nitro compound that is used in the synthesis of antibacterial drugs. It is also used in the production of polymers and as a precursor to other organic compounds. IDPS has been shown to have antibacterial activity against halogeno bacteria, such as buprestidae, and many Gram-positive bacteria, including encapsulated strains. IDPS has been shown to be effective against both damaged cells and healthy cells in culture. The mechanism of action may involve inhibition of protein synthesis by blocking the ribosomes or by interfering with DNA replication. This drug also inhibits growth rate of japonica rice and heterocycles.</p>

N4-Benzoyl-2'-deoxy-5'-O-pixylcytidine is a novel nucleoside that is structurally related to cytidine. It is synthesized from 2'-deoxycytidine monophosphate and 4-benzoylpixyl chloride. N4-Benzoyl-2'-deoxy-5'-O-pixylcytidine has antiviral, antiangiogenic and anticancer properties, as well as the ability to inhibit the replication of DNA in cells. This compound can be used for synthesis of phosphoramidites, which are used in the production of oligonucleotides.

<p>5-Fluorocytidine (5FC) is an antiviral drug that inhibits the synthesis of DNA. 5FC is a prodrug that is converted to cytosine in vivo, and then incorporated into viral DNA by polymerase chain reactions. The incorporation of 5FC into viral DNA prevents replication and transcription, which can lead to the death of cells infected with HIV. In addition, 5FC has been shown to be effective in treating chronic viral hepatitis and bowel diseases such as Crohn's disease. It also has potential use as a drug target for cancer treatments.<br>5FC has been shown to inhibit transcription activators in murine hepatoma cells and inhibit the growth of tumors in transfection experiments using human colon cancer cells. This antiviral agent has also been shown to have antimicrobial activity against Gram-positive bacteria, including Clostridium difficile, Staphylococcus aureus, Streptococcus pyogenes and Enterococcus faec</p>

<p>5-Methoxy-4’-thiouridine is a monophosphate nucleoside that is synthesized by the phosphorylation of 5-methoxy-4’-thioguanosine. It has antiviral activity, which is due to its ability to inhibit viral DNA polymerase and prevent the production of viral DNA. 5-Methoxy-4’-thiouridine also inhibits the synthesis of deoxyribonucleosides and ribonucleosides, thereby preventing the formation of RNA and DNA. This agent has been shown to be an anticancer agent that can cause cell death by inhibiting protein synthesis.</p>

<p>4’,5’-Didehydro-5’-deoxy-5-methyluridine is a monophosphate nucleoside that is used as an antiviral agent. It has been shown to be active in the treatment of HIV and hepatitis B. 4’,5’-Didehydro-5’-deoxy-5-methyluridine also has anticancer properties and has been shown to inhibit cell proliferation in vitro by interfering with DNA synthesis. This product is an intermediate for the synthesis of other nucleosides and phosphoramidites.</p>

2'-O-(N-Methylanthraniloyl)-3'-deoxy-adenosine-5'-triphosphate triethylammonium salt is a novel antiviral and anticancer compound. It is an analogue of adenosine, which inhibits the synthesis of viral RNA and DNA. This compound can also be used to treat certain types of cancer. 2'-O-(N-Methylanthraniloyl)-3'-deoxy-adenosine-5'-triphosphate triethylammonium salt is chemically synthesized by reacting anthranilic acid with 3',5'-dideoxyadenosine 5' triphosphoric acid.

<p>6-Amino-1-(2'-deoxy-b-D-ribofuranosyl)-4-hydroxyamino-1H-pyrazolo[3,4-d]pyrimidine is a modified nucleoside with antiviral and anticancer properties. It is an activator of ribonucleotide reductase, which converts ribonucleotides to deoxyribonucleotides. 6-Amino-1-(2'-deoxy-b-D-ribofuranosyl)-4-hydroxyamino-1H pyrazolo[3,4 d]pyrimidine can be used in the synthesis of phosphoramidites for DNA synthesis and for the production of monophosphate nucleotides. The compound has been shown to inhibit the growth of cells in culture that are resistant to other antiinfectives such as erythromycin and chloramphenicol.</p>

<p>monophosphate of 2-deoxy-5-hydroxymethyluridine</p>

3’-Deoxy-3’-fluoro-N6-hydroxyadenosine (3'-DF) is an antiviral nucleoside that inhibits viral DNA synthesis and has shown cytotoxic effects in human cancer cells. 3'-DF is a novel chemical compound that was first synthesized in 1994. It is a nucleotide analog that is structurally related to adenosine, with the exception of the fluoro atom at position 6 on the ribose sugar. 3'-DF inhibits DNA polymerase and RNA polymerase by competitively binding to the ribonucleotide reductase enzyme, inhibiting the production of new RNA and DNA molecules. This compound also has been shown to inhibit protein synthesis in cancer cells without affecting normal cells.

5-Fluoro-4’-C-methyluridine is a novel antiviral agent that is structurally related to the nucleoside analogue cytidine. It has been shown to be an activator of DNA polymerase, which may contribute to its antiviral activity. 5-Fluoro-4’-C-methyluridine has been shown to inhibit the growth of cancer cells by modifying the synthesis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). 5-Fluoro-4’-C-methyluridine has also been shown to have anticancer effects, as it inhibits cell proliferation and induces apoptosis.

<p>Isocytidine triphosphate triethylamine salt is a nucleoside that has been modified to include an amino group. It is a monophosphate, which means it contains one phosphate group. Isocytidine triphosphate triethylamine salt has shown anticancer properties as it inhibits the synthesis of DNA and RNA. This compound also prevents the activation of transcription factors, such as NF-κB, that are important in cancer cell proliferation.</p>

Intermediate in the synthesis of nelarabine

<p>5'-O-MMT-thymidine 3'-CE phosphoramidite is a novel anticancer drug that is modified from the natural nucleoside thymidine. It has been shown to inhibit the activity of DNA polymerase, preventing DNA synthesis and replication. It also inhibits viral DNA replication, including HIV and herpes simplex virus type-1 (HSV-1). 5'-O-MMT-thymidine 3'-CE phosphoramidite has antiviral properties against HIV and HSV-1. This nucleoside is synthesized by reacting 5'-O-methyl cytidylic acid with an activated phosphite in the presence of triethylamine in dichloromethane. The product is purified by column chromatography on silica gel and recrystallization from acetonitrile.</p>

N2-DMF-5'-O-DMT-2'-O-methylguanosine 3'-CE phosphoramidite is a novel ribonucleotide with high purity and high quality. It is an activator of DNA synthesis and can be used in the synthesis of DNA, monophosphate, and diphosphate. N2-DMF-5'-O-DMT-2'-O-methylguanosine 3'-CE phosphoramidite is used for the preparation of anticancer drugs, antiviral agents, and other nucleosides.

The 2'-O-tert-Butyldimethylsilyl-5'-O-DMT-N2-isobutyrylguanosine 3'-CE phosphoramidite is an oligomer with a modified nucleoside. The modification of the nucleoside has been shown to be more efficient than other modifications, such as fluorine or bromine substitutions. This product is used in the synthesis of DNA and RNA oligomers. The coupling efficiency is high and can be used for ligand binding studies.

2'-O-tert-Butyldimethylsilyl-5'-O-DMT-1-methylguanosine 3'-CE phosphoramidite is a synthetic, antiviral monophosphate nucleoside. It is an activator that increases the activity of other nucleosides and can be used in DNA synthesis by incorporation into DNA molecules. 2'-O-tert-Butyldimethylsilyl-5'-O-DMT-1-methylguanosine 3'-CE phosphoramidite has been shown to be effective against Hepatitis C virus, Human Immunodeficiency Virus 1 (HIV), and Herpes Simplex Virus 1.